Anhui Zhifei Longcom Biopharmaceutical Co.,Ltd.
|2008||It was wholly-owned by Chongqing Zhifei Biological Products Co.,Ltd|
|2010||Chongqing Zhifei Biological Products Co., Ltd. was listed on GEM of Shenzhen Stock Exchange|
|2011||Construction of biological products production and R & D center projects.|
|2013||Changed its name to Anhui Zhifei Longcom Biopharmaceutical Co., LTD.
Granted as a pharmaceutical GMP practice training base
|2014||Awarded with the high-tech enterprise certification for the first time
Granted with the title of Anhui Provincial Engineering research Center for Novel Human Vaccine
|2016||Granted as an Innovation Base of TB translational Medicine of China National Defense Tuberculosis Association|
|2018||Its biopharmaceutical Industrial Park (Area A) construction was officially started.|
|2020||Recombinant Mycobacterium tuberculosis fusion Protein (EC) (trade name: EC-Test ®) was approved for drug registration.|